MedCap AB (FRA:61MA) Cyclically Adjusted FCF per Share: €0.75 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:61MA MedCap AB FRA:61MA
91 GF Score
Price €46.18
GF Value €50.15
Valuation Fairly Valued
View Full Analysis

What is MedCap AB Cyclically Adjusted FCF per Share?

MedCap AB FRA:61MA -0.99% 91 Cyclically Adjusted FCF per Share is €0.75 as of Mar. 2026. GuruFocus rates FRA:61MA with a GF Score™ of 91/100 and a GF Value™ of €50.15 (Fairly Valued).

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

MedCap AB's adjusted free cash flow per share for the three months ended in Mar. 2026 was €0.219. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €0.75 for the trailing ten years ended in Mar. 2026.

During the past 12 months, MedCap AB's average Cyclically Adjusted FCF Growth Rate was 48.70% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 50.90% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 33.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of MedCap AB was 50.90% per year. The lowest was 14.30% per year. And the median was 20.40% per year.

As of today (2026-07-21), MedCap AB's current stock price is €46.18. MedCap AB's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €0.75. MedCap AB's Cyclically Adjusted Price-to-FCF of today is 61.57.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of MedCap AB was 147.07. The lowest was 57.44. And the median was 94.38.


MedCap AB  (FRA:61MA) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

MedCap AB's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=46.18/0.75
=61.57

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of MedCap AB was 147.07. The lowest was 57.44. And the median was 94.38.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


MedCap AB Cyclically Adjusted FCF per Share Related Terms


MedCap AB Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for MedCap AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MedCap AB Cyclically Adjusted FCF per Share Chart

MedCap AB Annual Data
Trend Apr16 Apr17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.20 0.20 0.28 0.47 0.71

MedCap AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.50 0.61 0.61 0.71 0.75

FRA:61MA vs ABT, SYK, MDT: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, MedCap AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedCap AB Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MedCap AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where MedCap AB's Cyclically Adjusted Price-to-FCF falls into.


FRA:61MA
91GF Score
MedCap AB FRA:61MA
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MedCap AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, MedCap AB's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.219/133.5600*133.5600
=0.219

Current CPI (Mar. 2026) = 133.5600.

MedCap AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201604 -0.110 100.732 -0.146
201607 -0.027 101.080 -0.036
201610 0.035 101.485 0.046
201701 0.226 101.326 0.298
201704 0.108 102.615 0.141
201707 -0.002 103.301 -0.003
201710 0.058 103.202 0.075
201803 0.129 103.962 0.166
201806 -0.023 104.875 -0.029
201809 -0.005 105.679 -0.006
201812 0.311 105.912 0.392
201903 0.178 105.886 0.225
201906 0.020 106.742 0.025
201909 0.063 107.214 0.078
201912 0.028 107.766 0.035
202003 0.148 106.563 0.185
202006 0.274 107.498 0.340
202009 -0.019 107.635 -0.024
202012 0.208 108.296 0.257
202103 0.067 108.360 0.083
202106 0.140 108.928 0.172
202109 0.099 110.338 0.120
202112 0.062 112.486 0.074
202203 0.251 114.825 0.292
202206 0.097 118.384 0.109
202209 0.228 122.296 0.249
202212 -0.304 126.365 -0.321
202303 0.268 127.042 0.282
202306 0.171 129.407 0.176
202309 0.296 130.224 0.304
202312 0.375 131.912 0.380
202403 0.441 132.205 0.446
202406 0.324 132.716 0.326
202409 0.348 132.304 0.351
202412 0.615 132.987 0.618
202503 0.251 132.825 0.252
202506 0.370 133.699 0.370
202509 0.305 133.480 0.305
202512 0.782 133.390 0.783
202603 0.219 133.560 0.219

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €0.75 mean?
MedCap AB (FRA:61MA) has a Cyclically Adjusted FCF per Share of €0.75 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on MedCap AB and its competitors.
Is MedCap AB's Cyclically Adjusted FCF per Share too high?
MedCap AB's current Cyclically Adjusted FCF per Share is €0.75. Overall, MedCap AB has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does MedCap AB's Cyclically Adjusted FCF per Share compare to ABT and SYK?
MedCap AB's Cyclically Adjusted FCF per Share of €0.75 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on MedCap AB and its competitors. MedCap AB's current Cyclically Adjusted FCF per Share is €0.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedCap AB stock overvalued right now?
Based on GuruFocus' analysis, MedCap AB (FRA:61MA) is currently considered Fairly Valued. The stock's GF Value™ is €50.15, compared to a current price of €46.18 — trading 7.9% below its estimated fair value. The current Cyclically Adjusted FCF per Share is €0.75. MedCap AB's overall GF Score™ is 91/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For MedCap AB (FRA:61MA), the current Cyclically Adjusted FCF per Share is €0.75 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MedCap AB (FRA:61MA) Overvalued in 2026?

Based on GuruFocus' analysis, MedCap AB stock appears to be undervalued. The current stock price of €46.18 is trading 7.9% below its estimated GF Value™ of €50.15. GuruFocus considers MedCap AB to be Fairly Valued.

Key valuation signals for FRA:61MA:

  • Cyclically Adjusted FCF per Share: €0.75
  • GF Value™: €50.15 vs. price of €46.18 (7.9% below fair value)
  • GF Score™: 91/100

No single metric tells the full story. See the FRA:61MA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MedCap AB Business Description

Address Sundbybergsvagen 1, Solna, SWE, 171 73
MedCap AB acquires and develops profitable, market-leading niche companies in the Nordic life science industry. It is diversified into two business areas namely Medical technology and Specialist medicines. Medical Technology mainly develops and sells various medical technology products and services. Its Specialist medicines develop and sell medicines within the regulatory classes of registered, extemporaneous and licensed medicines.
91GF Score

Get the complete analysis for FRA:61MA

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€46.18
Price
€50.15
GF Value